These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26348977)
1. Epigenetic Regulation of Antibody Responses by the Histone H2A Deubiquitinase MYSM1. Jiang XX; Chou Y; Jones L; Wang T; Sanchez S; Huang XF; Zhang L; Wang C; Chen SY Sci Rep; 2015 Sep; 5():13755. PubMed ID: 26348977 [TBL] [Abstract][Full Text] [Related]
2. Control of B cell development by the histone H2A deubiquitinase MYSM1. Jiang XX; Nguyen Q; Chou Y; Wang T; Nandakumar V; Yates P; Jones L; Wang L; Won H; Lee HR; Jung JU; Müschen M; Huang XF; Chen SY Immunity; 2011 Dec; 35(6):883-96. PubMed ID: 22169041 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic control of natural killer cell maturation by histone H2A deubiquitinase, MYSM1. Nandakumar V; Chou Y; Zang L; Huang XF; Chen SY Proc Natl Acad Sci U S A; 2013 Oct; 110(41):E3927-36. PubMed ID: 24062447 [TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses. White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic control of dendritic cell development and fate determination of common myeloid progenitor by Mysm1. Won H; Nandakumar V; Yates P; Sanchez S; Jones L; Huang XF; Chen SY Blood; 2014 Oct; 124(17):2647-56. PubMed ID: 25217698 [TBL] [Abstract][Full Text] [Related]
6. The control of hematopoietic stem cell maintenance, self-renewal, and differentiation by Mysm1-mediated epigenetic regulation. Wang T; Nandakumar V; Jiang XX; Jones L; Yang AG; Huang XF; Chen SY Blood; 2013 Oct; 122(16):2812-22. PubMed ID: 24014243 [TBL] [Abstract][Full Text] [Related]
7. The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation. Lu D; Nakagawa R; Lazzaro S; Staudacher P; Abreu-Goodger C; Henley T; Boiani S; Leyland R; Galloway A; Andrews S; Butcher G; Nutt SL; Turner M; Vigorito E J Exp Med; 2014 Oct; 211(11):2183-98. PubMed ID: 25288398 [TBL] [Abstract][Full Text] [Related]
8. The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells. Grötsch B; Brachs S; Lang C; Luther J; Derer A; Schlötzer-Schrehardt U; Bozec A; Fillatreau S; Berberich I; Hobeika E; Reth M; Wagner EF; Schett G; Mielenz D; David JP J Exp Med; 2014 Oct; 211(11):2199-212. PubMed ID: 25288397 [TBL] [Abstract][Full Text] [Related]
9. Immunology. End game for B cells. Calame K Nature; 2001 Jul; 412(6844):289-90. PubMed ID: 11460147 [No Abstract] [Full Text] [Related]
10. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. Muto A; Ochiai K; Kimura Y; Itoh-Nakadai A; Calame KL; Ikebe D; Tashiro S; Igarashi K EMBO J; 2010 Dec; 29(23):4048-61. PubMed ID: 20953163 [TBL] [Abstract][Full Text] [Related]
11. The critical role of histone H2A-deubiquitinase Mysm1 in hematopoiesis and lymphocyte differentiation. Nijnik A; Clare S; Hale C; Raisen C; McIntyre RE; Yusa K; Everitt AR; Mottram L; Podrini C; Lucas M; Estabel J; Goulding D; ; ; Adams N; Ramirez-Solis R; White JK; Adams DJ; Hancock RE; Dougan G Blood; 2012 Feb; 119(6):1370-9. PubMed ID: 22184403 [TBL] [Abstract][Full Text] [Related]
12. MYSM1/miR-150/FLT3 inhibits B1a cell proliferation. Jiang XX; Liu Y; Li H; Gao Y; Mu R; Guo J; Zhang J; Yang YM; Xiao F; Liu B; Wang C; Shen B; Chen SY; Li Z; Yang G Oncotarget; 2016 Oct; 7(42):68086-68096. PubMed ID: 27590507 [TBL] [Abstract][Full Text] [Related]
13. Chromatin-binding deubiquitinase MYSM1 acts in haematopoietic progenitors to control dendritic cell development and to program dendritic cell responses to microbial stimulation. Mousa M; Liang Y; Tung LT; Wang H; Krawczyk C; Langlais D; Nijnik A Immunology; 2024 May; 172(1):109-126. PubMed ID: 38316548 [TBL] [Abstract][Full Text] [Related]
14. A role for the histone H2A deubiquitinase MYSM1 in maintenance of CD8 Förster M; Boora RK; Petrov JC; Fodil N; Albanese I; Kim J; Gros P; Nijnik A Immunology; 2017 May; 151(1):110-121. PubMed ID: 28066899 [TBL] [Abstract][Full Text] [Related]
15. MYSM1-dependent checkpoints in B cell lineage differentiation and B cell-mediated immune response. Förster M; Farrington K; Petrov JC; Belle JI; Mindt BC; Witalis M; Duerr CU; Fritz JH; Nijnik A J Leukoc Biol; 2017 Mar; 101(3):643-654. PubMed ID: 27895164 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984 [TBL] [Abstract][Full Text] [Related]
18. Repression of the transcription factor Bach2 contributes to predisposition of IgG1 memory B cells toward plasma cell differentiation. Kometani K; Nakagawa R; Shinnakasu R; Kaji T; Rybouchkin A; Moriyama S; Furukawa K; Koseki H; Takemori T; Kurosaki T Immunity; 2013 Jul; 39(1):136-47. PubMed ID: 23850379 [TBL] [Abstract][Full Text] [Related]
19. [Deubiquitinase MYSM1 Regulates Differentiation of Human B Cells to Plasma Cells]. Zhong KL; Huang XH; Wang YH; Wang B; Wang WX; Wang YH; Zhang WJ; Jiang XX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1627-1632. PubMed ID: 31607324 [TBL] [Abstract][Full Text] [Related]
20. Accelerated plasma-cell differentiation in Bach2-deficient mouse B cells is caused by altered IRF4 functions. Ochiai K; Shima H; Tamahara T; Sugie N; Funayama R; Nakayama K; Kurosaki T; Igarashi K EMBO J; 2024 May; 43(10):1947-1964. PubMed ID: 38605225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]